Harvard Bioscience Inc (HBIO)
CIK 1123494 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Harvard Bioscience Inc.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 11, 2026 | 10-Q | 0001171843-26-005425 |
| Aug 11, 2026 | 8-K | 0001171843-26-005406 |
| Aug 11, 2026 | 8-K | 0001171843-26-005405 |
| Jun 12, 2026 | 4 | 0001171843-26-004082 |
| Jun 11, 2026 | 4 | 0001171843-26-004057 |
| Jun 11, 2026 | 4 | 0001171843-26-004060 |
| Jun 11, 2026 | 4 | 0001171843-26-004058 |
| Jun 11, 2026 | 4 | 0001171843-26-004056 |
| Jun 10, 2026 | S-8 | 0001171843-26-004037 |
| Jun 2, 2026 | 8-K | 0001171843-26-003877 |
| May 27, 2026 | SD | 0001171843-26-003718 |
| May 14, 2026 | SCHEDULE 13G/A | 0001019432-26-000010 |
| May 12, 2026 | 10-Q | 0001171843-26-003311 |
| May 12, 2026 | 8-K | 0001171843-26-003270 |
| May 12, 2026 | 8-K | 0001171843-26-003271 |
| Apr 21, 2026 | DEF 14A | 0001171843-26-002617 |
| Apr 21, 2026 | DEFA14A | 0001171843-26-002623 |
| Apr 1, 2026 | 4 | 0001171843-26-002155 |
| Apr 1, 2026 | 4 | 0001171843-26-002156 |
| Mar 23, 2026 | SCHEDULE 13D | 0001171843-26-001839 |
| Mar 23, 2026 | 4 | 0001171843-26-001843 |
| Mar 18, 2026 | 4 | 0001171843-26-001689 |
| Mar 18, 2026 | 4 | 0001171843-26-001732 |
| Mar 17, 2026 | 8-K | 0001171843-26-001614 |
| Mar 17, 2026 | 4 | 0001171843-26-001645 |